Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Radiotherapy Concurrently Combined With Cisplatin and Nimotuzumab for Patients With Locally Advanced Cervical Cancer

NCT02705612 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT02705612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02705612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Radiotherapy Concurrently Combined With Cisplatin and Nimotuzumab for Patients With Locally Advanced Cervical Cancer
Lead sponsor
Air Force Military Medical University, China
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2015
Completion date
September 30, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer